Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBIT Margin (2024 - 2025)

Rallybio's EBIT Margin history spans 2 years, with the latest figure at 3266.51% for Q3 2025.

  • For Q3 2025, EBIT Margin rose 76894.0% year-over-year to 3266.51%; the TTM value through Sep 2025 reached 5996.87%, up 570882.0%, while the annual FY2024 figure was 10082.67%, N/A changed from the prior year.
  • EBIT Margin for Q3 2025 was 3266.51% at Rallybio, up from 4743.87% in the prior quarter.
  • Across five years, EBIT Margin topped out at 3266.51% in Q3 2025 and bottomed at 580400.0% in Q4 2024.